Stimuli-Responsive Polymeric Nanoparticles for Targeted and Controlled Drug Delivery: From Molecular Design to Clinical Translation: A Review
Abstract
Background: Stimuli-responsive polymeric nanoparticles (PNPs) have emerged as smart drug delivery systems capable of releasing therapeutic agents selectively in response to physiological or external stimuli. Recent advances in polymer engineering, surface functionalization, and multi-stimuli responsiveness have expanded their biomedical applications.Objective: This review aims to summarize recent developments (2023–2025) in stimuli-responsive PNPs, focusing on their design strategies, therapeutic applications, performance improvements, and challenges associated with clinical translation.Methods: Recent studies investigating stimuli-responsive PNPs were analyzed with emphasis on polymer composition, surface modification techniques, multi-stimuli architectures, and their applications in cancer therapy, gene therapy, immunotherapy, infectious diseases, and metabolic disorders.Results: The reviewed studies demonstrated significant improvements in drug stability, controlled release kinetics, targeting efficiency, and biocompatibility of PNP systems. These advances resulted in enhanced therapeutic efficacy in preclinical and early clinical studies. However, several limitations remain, including challenges related to large-scale manufacturing, production costs, regulatory approval, and long-term safety evaluation.Conclusion: Stimuli-responsive PNPs represent a promising platform for next-generation nanomedicine due to their precision, versatility, and therapeutic efficiency. Future progress is expected through the integration of artificial intelligence, personalized medicine strategies, and scalable manufacturing technologies such as continuous-flow microfluidics, which may facilitate successful clinical translation.